How Similar Are Biosimilar Insulins?

Host: Raj Chovatiya, MD, PhD
Guest: Martina J. Porter, MD

For patients with hidradenitis suppurativa (HS), the exact cause of the condition is still being researched. So what therapies are currently available to treat this painful condition? To discuss what you need to know, Dr. Raj Chovatiya is joined by Dr. Martina Porter, Dermatologist at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical School.

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
Guest: David Weisman, MD

Alzheimer’s disease is the most common form of dementia, and symptoms become more severe over time. In fact, it’s the leading cause of disability and poor health in older adults. And although there’s no cure, a new medication called lecanemab recently received accelerated approval by the US Food and Drug Administration. So what might this new development mean for the 6 million Americans living with this debilitating disease? Find out as Dr. Andrew Wilner speaks with fellow ReachMD host Dr. David Weisman, who’s also the Director of Clinical Research at Abington Neurological Associates.

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Brennan Spiegel, MD, MSHS

The pathogenesis of irritable bowel syndrome (IBS) remains unclear, but according to one professor, gravity may play a bigger role in this condition than we think. Dr. Peter Buch sits down with Dr. Brennen Spiegel from the Cedars Sinai Center for Outcomes Research and Education to dive into his research on gravitational management systems and IBS.

Host: Peter Buch, MD, FACG, AGAF, FACP
Guest: Kyle Staller, MD, MPH

Chronic abdominal pain can be caused by many things—including hereditary angioedema (HAE). Are there any barriers to diagnosing patients with HAE? Dr. Peter Buch speaks with Dr. Kyle Staller from the Gastrointestinal Motility Laboratory at Mass General to explore the differential diagnosis for HAE and share what clinicians should be on the lookout for.

Host: Mario R. Nacinovich, Jr., MSc
Guest: Gregory Sepich-Poore, MD/PhD

Results from a recent study detail the impact that fungi can have in human cancer tumors. What do we need to know? Mario Nacinovich speaks with one of the researchers, Dr. Gregory Sepich-Poore from UC San Diego, to dive further into these results and their impact on cancer therapeutics.

Host: Pavani Chalasani, MD, MPH
Guest: Hope S. Rugo, MD, FASCO

Results from the TROPiCS-02 trial may impact survival for patients with receptor–positive/HER2-negative breast cancer. To find out why, Dr. Hope Rugo from the University of California San Francisco Comprehensive Cancer Center joins Dr. Pavani Chalasani to talk about the study and how it might impact the future of breast cancer treatment.

Host: Jennifer Caudle, DO
Guest: Kathleen Blake, MD, MPH
Guest: Peggy Chen, MD

Behavioral health integration has proven to be an effective solution to improving access to treatment for many mental health conditions… So why is it not more prevalent in the medical community? Joining Dr. Jennifer Caudle to dive into the findings and implications of the joint AMA-RAND Corporation study recently published in the Annals of Internal Medicine are Dr. Kathleen Blake with the AMA and Dr. Peggy Chen from the RAND Corporation.

And, click here to listen to a conversation regarding Behavioral Health Integration and its effect on clinical practice.

Host: Matt Birnholz, MD
Guest: Emeran Mayer, MD, PhD

There’s no organ in the body that has such close connections with the brain as the gut, which can often result in pain for many of our patients with IBD. Listen in as Dr. Emeran Mayer joins Dr. Matt Birnholz to explain this mind-gut connection, why patients with IBD experience pain, and how providers can manage patients who experience pain when inflammation is and isn't present.

Host: Matt Birnholz, MD
Guest: Mark R. Cullen, MD

Here to share what we might soon learn about the COVID-19 pandemic is Dr. Mark Cullen, Scientific Committee Chair for the academic arm of the COVID-19 research database, which is a secure repository of HIPAA compliant, de-identified, and limited patient-level data sets.

Published May 13, 2020

Host: Mario R. Nacinovich, Jr., MSc
Guest: Mark R. Cullen, MD

Even before the COVID-19 pandemic hit, endemic challenges surrounded fragmented data sets and long perspective clinical trials. But now, recently developed data sets are available to public health and policy researchers to not only overcome that challenge, but also to combat this global pandemic. Dr. Mark Cullen, Scientific Committee Chair for the academic arm of the COVID-19 research database at Stanford University School of Medicine, joins Mario Nacinovich to explain.

Published May 13, 2020